1 recruiting, 1 suspended. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Suspended 1 |
Follow Craniosynostoses: new trials by email Literature Review of Craniosynostoses trials Research Report on Craniosynostoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer Futibatinib, Zimberelimab, Durvalumab - Biliary Tract Cancer | Phase 3 | Recruiting | Taiho Pharmaceutical Co., Ltd. | 784 | 2026-06-24 | 2026-07-17 |
| Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid Tranexamic Acid, Saline Placebo - Craniosynostoses | Phase 3 | Suspended | The Hospital for Sick Children | 90 | 2010-01-01 | 2019-07-15 |
Acrocephalosyndactylia (1) · Biliary Tract Neoplasms (1) · Hemorrhage (1) · Parkinson Disease 4, Autosomal Dominant Lewy Body (1)
Bone Diseases (2) · Bone Diseases, Developmental (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Craniofacial Abnormalities (2) · Dysostoses (2) · Musculoskeletal Abnormalities (2) · Musculoskeletal Diseases (2) · Synostosis (2) · Biliary Tract Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Limb Deformities, Congenital (1) · Neoplasms (1)
Cisplatin (1) · Gemcitabine (1) · Tranexamic Acid (1) · durvalumab (1) · futibatinib (1) · pembrolizumab (1) · zimberelimab (1)
Taiho Pharmaceutical Co., Ltd. (1) · The Hospital for Sick Children (1)
Australia (1) · Canada (1) · Japan (1) · South Korea (1) · Thailand (1)
Tara Der, MD (1)